CytomX Therapeutics
CTMX
CTMX
117 hedge funds and large institutions have $298M invested in CytomX Therapeutics in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 41 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
2% less funds holding
Funds holding: 119 → 117 (-2)
11% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 19
Holders
117
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$24.2M | |
| 2 | +$21M | |
| 3 | +$2.3M | |
| 4 |
Renaissance Technologies
New York
|
+$1.11M |
| 5 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$1.07M |
Top Sellers
| 1 | -$3.87M | |
| 2 | -$2.97M | |
| 3 | -$2.18M | |
| 4 |
Goldman Sachs
New York
|
-$2.01M |
| 5 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$1.87M |